Retinitis Pigmentosa Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa Interventions: Drug: OCU400 Low Dose; Drug: OCU400 Mid Dose; Drug: OCU400 High Dose Sponsor: Ocugen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2022 Category: Research Source Type: clinical trials
An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa; Usher Syndrome Type 2 Intervention: Drug: RNA antisense oligonucleotide for intravitreal injection Sponsor: ProQR Therapeutics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2021 Category: Research Source Type: clinical trials
